Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

iTAPP Declares Radiometer’s AQT90 FLEX a ‘High Impact Innovation’

Published: Wednesday, November 06, 2013
Last Updated: Wednesday, November 06, 2013
Bookmark and Share
AQT90 FLEX analyzer’s advanced technology allows rapid, laboratory standard testing.

Radiometer’s AQT90 FLEX immunoassay analyzer has been identified by the Innovative Technology Adoption Procurement Programme (iTAPP) as being significant to the NHS Quality, Innovation, Productivity and Prevention (QIPP) agenda, with the benefits it offers to the wider health economy being explored at local, regional and national level.

Diagnosis and treatment of patients presenting to emergency departments, coagulation clinics or early pregnancy units is highly dependent on prompt receipt of pathology results.

The AQT90 FLEX analyzer’s advanced technology allows rapid, laboratory standard testing of a comprehensive panel of cardiac markers, as well as D-dimer, CRP and β-hCG, at the point of care.

The fully automated process uses a closed tube system, eliminating time-consuming manual sample preparation and reducing the risk of staff coming into contact with biological fluids.

Accurate results are consistently generated in less than 20 minutes, enabling faster diagnosis and treatment, and prompt clinical decision making.

This capability - allowing clinicians to quickly rule in or out conditions such as acute coronary syndrome, congestive heart failure, DVT, pulmonary embolisms, acute infections and pregnancy - significantly improves productivity, and patient management and outcomes.

The AQT90 Briefing Pack, published through the NHS Technology Adoption Centre, has been fully integrated into the NICE Health Technologies Adoption Programme, providing comprehensive documentation that demonstrates how the system can yield real, significant and sustainable benefits for local healthcare services.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
A Leap Forward in Vaccinating Against HIV
A team of scientists has developed an experimental vaccine candidate that successfully stimulates the immune system activity in animal models necessary to stop HIV infection.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!